FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2915471276> ?p ?o ?g. }

• W2915471276 endingPage "787" @default.
• W2915471276 startingPage "787" @default.
• W2915471276 abstract "Purpose: To evaluate whether baseline titers of anti-fumarase antibody are associated with visual prognosis after anti-VEGF treatment for diabetic macular edema (DME). Methods: In this retrospective study, we investigated 52 eyes of 52 DME patients who received intravitreal injections of anti-VEGF drugs (ranibizumab or aflibercept) after blood sampling at baseline. Optical coherence tomography (OCT) images were obtained at every monthly visit. The serum titer of anti-fumarase antibody at baseline was measured using ELISA. We evaluated the relationship between the titer of anti-fumarase antibody at baseline and visual acuity (VA) improvement at 12 months. Results: The serum titer of anti-fumarase IgG was related to the logMAR visual acuity (VA; R = 0.329, P = 0.017) and the disrupted ellipsoid zone (EZ; R = 0.364, P = 0.008) at baseline. The titer of this autoantibody was not associated with logMAR VA (R = −0.007, P = 0.980) but was associated with VA improvement (R = 0.465, P < 0.001) at 12 months upon anti-VEGF treatment. The transverse length of the disrupted EZ line was shortened at 12 months (P < 0.001), and restoration of the EZ line was correlated to the autoantibody titer (R = 0.396, P = 0.004) compared with the decrease in central subfield (CSF) thickness. Multivariate analysis showed that pretreatment logMAR VA (β = 0.296, P = 0.045) and the autoantibody titer (β = 0.328, P = 0.017) were associated with VA improvement after anti-VEGF treatment. In contrast, the titer was not associated with logMAR VA at 12 months. Conclusions: Anti-fumarase antibody is a novel serum biomarker predicting better functional efficacy of anti-VEGF treatment for DME." @default.
• W2915471276 created "2019-03-02" @default.
• W2915471276 creator A5011405789 @default.
• W2915471276 creator A5043984281 @default.
• W2915471276 creator A5049463882 @default.
• W2915471276 creator A5075752707 @default.
• W2915471276 creator A5075999926 @default.
• W2915471276 creator A5076989043 @default.
• W2915471276 creator A5089022455 @default.
• W2915471276 date "2019-02-26" @default.
• W2915471276 modified "2023-09-23" @default.
• W2915471276 title "Anti-Fumarase Antibody as a Predictor of Functional Efficacy of Anti-VEGF Therapy for Diabetic Macular Edema" @default.
• W2915471276 cites W127872553 @default.
• W2915471276 cites W1851754610 @default.
• W2915471276 cites W1975886575 @default.
• W2915471276 cites W1990374749 @default.
• W2915471276 cites W1991156200 @default.
• W2915471276 cites W1997957340 @default.
• W2915471276 cites W1999957425 @default.
• W2915471276 cites W2000552582 @default.
• W2915471276 cites W2007155254 @default.
• W2915471276 cites W2019616115 @default.
• W2915471276 cites W2022132346 @default.
• W2915471276 cites W2022886290 @default.
• W2915471276 cites W2025500570 @default.
• W2915471276 cites W2040037866 @default.
• W2915471276 cites W2051420632 @default.
• W2915471276 cites W2051556121 @default.
• W2915471276 cites W2081251302 @default.
• W2915471276 cites W2086373795 @default.
• W2915471276 cites W2091729420 @default.
• W2915471276 cites W2092638574 @default.
• W2915471276 cites W2102463203 @default.
• W2915471276 cites W2114208662 @default.
• W2915471276 cites W2125232760 @default.
• W2915471276 cites W2127013658 @default.
• W2915471276 cites W2138480916 @default.
• W2915471276 cites W2146624780 @default.
• W2915471276 cites W2156799887 @default.
• W2915471276 cites W2161279821 @default.
• W2915471276 cites W2165446988 @default.
• W2915471276 cites W2166550261 @default.
• W2915471276 cites W2173144648 @default.
• W2915471276 cites W2318537063 @default.
• W2915471276 cites W2331655836 @default.
• W2915471276 cites W2517664365 @default.
• W2915471276 cites W2533805916 @default.
• W2915471276 cites W2536221331 @default.
• W2915471276 cites W2564805400 @default.
• W2915471276 cites W2594136717 @default.
• W2915471276 cites W2616361514 @default.
• W2915471276 cites W2785286954 @default.
• W2915471276 cites W2801682994 @default.
• W2915471276 cites W2802987970 @default.
• W2915471276 cites W2902325717 @default.
• W2915471276 cites W2992938564 @default.
• W2915471276 cites W4233230329 @default.
• W2915471276 cites W4244017022 @default.
• W2915471276 doi "https://doi.org/10.1167/iovs.18-26209" @default.
• W2915471276 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30807637" @default.
• W2915471276 hasPublicationYear "2019" @default.
• W2915471276 type Work @default.
• W2915471276 sameAs 2915471276 @default.
• W2915471276 citedByCount "4" @default.
• W2915471276 countsByYear W29154712762020 @default.
• W2915471276 countsByYear W29154712762022 @default.
• W2915471276 countsByYear W29154712762023 @default.
• W2915471276 crossrefType "journal-article" @default.
• W2915471276 hasAuthorship W2915471276A5011405789 @default.
• W2915471276 hasAuthorship W2915471276A5043984281 @default.
• W2915471276 hasAuthorship W2915471276A5049463882 @default.
• W2915471276 hasAuthorship W2915471276A5075752707 @default.
• W2915471276 hasAuthorship W2915471276A5075999926 @default.
• W2915471276 hasAuthorship W2915471276A5076989043 @default.
• W2915471276 hasAuthorship W2915471276A5089022455 @default.
• W2915471276 hasBestOaLocation W29154712761 @default.
• W2915471276 hasConcept C118487528 @default.
• W2915471276 hasConcept C126322002 @default.
• W2915471276 hasConcept C159654299 @default.
• W2915471276 hasConcept C163764329 @default.
• W2915471276 hasConcept C203014093 @default.
• W2915471276 hasConcept C22889606 @default.
• W2915471276 hasConcept C2776694085 @default.
• W2915471276 hasConcept C2777802072 @default.
• W2915471276 hasConcept C2778257484 @default.
• W2915471276 hasConcept C2780347916 @default.
• W2915471276 hasConcept C2781100027 @default.
• W2915471276 hasConcept C32611913 @default.
• W2915471276 hasConcept C71924100 @default.
• W2915471276 hasConceptScore W2915471276C118487528 @default.
• W2915471276 hasConceptScore W2915471276C126322002 @default.
• W2915471276 hasConceptScore W2915471276C159654299 @default.
• W2915471276 hasConceptScore W2915471276C163764329 @default.
• W2915471276 hasConceptScore W2915471276C203014093 @default.
• W2915471276 hasConceptScore W2915471276C22889606 @default.
• W2915471276 hasConceptScore W2915471276C2776694085 @default.
• W2915471276 hasConceptScore W2915471276C2777802072 @default.
• W2915471276 hasConceptScore W2915471276C2778257484 @default.

• next